Therapy-related myelodysplasia in a patient with Rothmund-Thomson syndrome

European Journal of Haematology

Volumn 86, Issue 6, 2011, Pages 536-540

  Carlson, Aaron M ^a   Lindor, Noralane M ^b   Litzow, Mark R ^b  

^a MAYO CLINIC COLLEGE OF MEDICINE   (United States)

^b MAYO CLINIC   (United States)

Author keywords

Acute myelogenous leukemia; Myelodysplastic syndromes; Peripheral blood stem cell transplantation; RecQL4 helicase; Rothmund Thomson syndrome

Indexed keywords

5 AZA 2' DEOXYCYTIDINE; ALEMTUZUMAB; ALPHA INTERFERON; CYTARABINE; DOXORUBICIN; ETOPOSIDE; FLUDARABINE; IFOSFAMIDE; MELPHALAN; METHOTREXATE; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR; RECOMBINANT GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; TACROLIMUS; THALIDOMIDE;

ABOVE KNEE AMPUTATION; ACUTE GRANULOCYTIC LEUKEMIA; ACUTE MYELOBLASTIC LEUKEMIA; ADOLESCENT; ALLOGENEIC PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; ARTICLE; BONE MARROW BIOPSY; BONE SCINTISCANNING; CANCER RELAPSE; CASE REPORT; CHILD; CHROMOSOME ANALYSIS; CHROMOSOME MOSAICISM; CHRONIC GRAFT VERSUS HOST DISEASE; CYTOMEGALOVIRUS INFECTION; DISEASE COURSE; DRUG DOSE REDUCTION; FLUORESCENCE IN SITU HYBRIDIZATION; GRAFT VERSUS HOST REACTION; HUMAN; LUNG NODULE; MALE; MUCOSA INFLAMMATION; MULTIPLE CYCLE TREATMENT; MYELODYSPLASTIC SYNDROME; NEEDLE BIOPSY; NERVE INJURY; NONSENSE MUTATION; OSTEOSARCOMA; PANCYTOPENIA; PRIORITY JOURNAL; RASH; RECURRENT DISEASE; REFRACTORY ANEMIA; ROTHMUND THOMSON SYNDROME; THROMBOCYTE TRANSFUSION; THROMBOCYTOPENIA; TRISOMY 21; TUMOR NECROSIS; VIREMIA;

ADULT; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BONE NEOPLASMS; CHILD; CHROMOSOME ABERRATIONS; COMBINED MODALITY THERAPY; FATAL OUTCOME; FEMALE; HUMANS; MUTATION; MYELODYSPLASTIC SYNDROMES; NEOPLASM RECURRENCE, LOCAL; OSTEOSARCOMA; PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; RECQ HELICASES; ROTHMUND-THOMSON SYNDROME;

EID: 79956060327     PISSN: 09024441     EISSN: 16000609     Source Type: Journal    
DOI: 10.1111/j.1600-0609.2011.01609.x     Document Type: Article

References (32)

1. Larizza L, Roversi G, Volpi L. Rothmund-Thomson syndrome. Orphanet J Rare Dis 2010;5:16.
2. Wang LL, Levy ML, Lewis RA, Chintagumpala MM, Lev D, Rogers M, Plon SE. Clinical manifestations in a cohort of 41 Rothmund-Thomson syndrome patients. Am J Med Genet 2001;102:11-7.
3. Rothmund A. Uber Kataract in Vebindung mit Einer Eugntumliche Haut Degeneration. Arch Ophthalmol 1887;4:159.
4. Thomson M. A hitherto undescribed familial disease. Br J Dermatol 1923;35:455-62.
5. Wang LL, Gannavarapu A, Kozinetz CA, et al. Association between osteosarcoma and deleterious mutations in the RECQL4 gene in Rothmund-Thomson syndrome. J Natl Cancer Inst 2003;95:669-74.
6. Kitao S, Shimamoto A, Goto M, Miller RW, Smithson WA, Lindor NM, Furuichi Y. Mutations in RECQL4 cause a subset of cases of Rothmund-Thomson syndrome. Nat Genet 1999;22:82-4.
7. Ilhan I, Arikan U, Buyukpamukcu M. Myelodysplastic syndromes and RTS. Pediatr Hematol Oncol 1996;13:197.
8. Narayan S, Fleming C, Trainer AH, Craig JA. Rothmund-Thomson syndrome with myelodysplasia. Pediatr Dermatol 2001;18:210-2.
9. Rizzari C, Bacchiocchi D, Rovelli A, Biondi A, CantuRajnoldi A, Uderzo C, Masera G. Myelodysplastic syndrome in a child with Rothmund-Thomson syndrome: a case report. J Pediatr Hematol Oncol 1996;18:96-7.
10. Knoell KA, Sidhu-Malik NK, Malik RK. Aplastic anemia in a patient with Rothmund-Thomson syndrome. J Pediatr Hematol Oncol 1999;21:444-6.
11. Porter WM, Hardman CM, Abdalla SH, Powles AV. Haematological disease in siblings with Rothmund-Thomson syndrome. Clin Exp Dermatol 1999;24:452-4.
12. Hicks MJ, Roth JR, Kozinetz CA, Wang LL. Clinicopathologic features of osteosarcoma in patients with Rothmund-Thomson syndrome. J Clin Oncol 2007;25:370-5.
13. Lindor NM, Devries EMG, Michels VV, Schad CR, Jalal SM, Donovan KM, Smithson WA, Kvols LK, Thibodeau SN, Dewald GW. Rothmund-Thomson syndrome in siblings: evidence for acquired in vivo mosaicism. Clin Genet 1996;49:124-9.
14. Arellano ML, Langston A, Winton E, Flowers CR, Waller EK. Treatment of relapsed acute leukemia after allogeneic transplantation: a single center experience. Biol Blood Marrow Transplant 2007;13:116-23.
15. Aung L, Gorlick RG, Shi W, Thaler H, Shorter NA, Healey JH, Huvos AG, Meyers PA. Second malignant neoplasms in long-term survivors of osteosarcoma - Memorial Sloan-Kettering Cancer Center Experience. Cancer 2002;95:1728-34.
16. Smith MA, Rubinstein L, Anderson JR, et al. Secondary leukemia or myelodysplastic syndrome after treatment with epipodophyllotoxins. J Clin Oncol 1999;17:569-77.
17. Czader M, Orazi A. Therapy-related myeloid neoplasms. Am J Clin Pathol 2009;132:410-25.
18. Darrington DL, Vose JM, Anderson JR, Bierman PJ, Bishop MR, Chan WC, Morris ME, Reed EC, Sanger WG, Tarantolo SR. Incidence and characterization of secondary myelodysplastic syndrome and acute myelogenous leukemia following high-dose chemoradiotherapy and autologous stem-cell transplantation for lymphoid malignancies. J Clin Oncol 1994;12:2527-34.
19. Larson RA. Therapy-related myeloid neoplasms. Haematologica 2009;94:454-9.
20. Smith SM, Le Beau MM, Huo D, Karrison T, Sobecks RM, Anastasi J, Vardiman JW, Rowley JD, Larson RA. Clinical-cytogenetic associations in 306 patients with therapy-related myelodysplasia and myeloid leukemia: the University of Chicago series. Blood 2003;102:43-52.
21. Steensma DP, Bennett JM. The myelodysplastic syndromes: diagnosis and treatment. Mayo Clin Proc 2006;81:104-30.
22. Sharma S, Stumpo DJ, Balajee AS, Bock CB, Lansdorp PM, Brosh RM, Blackshear PJ. RECQL, a member of the RecQ family of DNA helicases, suppresses chromosomal instability. Mol Cell Biol 2007;27:1784-94.
23. Thangavel S, Mendoza-Maldonado R, Tissino E, Sidorova JM, Yin JH, Wang WD, Monnat RJ, Falaschi A, Vindigni A. Human RECQ1 and RECQ4 helicases play distinct roles in DNA replication initiation. Mol Cell Biol 2010;30:1382-96.
24. Xu XH, Liu YL. Dual DNA unwinding activities of the Rothmund-Thomson syndrome protein, RECQ4. EMBO J 2009;28:568-77.
25. Schurman SH, Hedayati M, Wang ZM, et al. Direct and indirect roles of RECQL4 in modulating base excision repair capacity. Hum Mol Genet 2009;18:3470-83.
26. Werner SR, Prahalad AK, Yang J, Hock JM. RECQL4-deficient cells are hypersensitive to oxidative stress/damage: insights for osteosarcoma prevalence and heterogeneity in Rothmund-Thomson syndrome. Biochem Biophys Res Commun 2006;345:403-9.
27. Auerbach AD. Fanconi-anemia. Dermatol Clin 1995;13:41-9.
28. Schwartz RS, D'Andrea AD. Susceptibility pathways in Fanconi's anemia and breast cancer. N Engl J Med 2010;362:1909-19.
29. Alter BP. Cancer in Fanconi anemia, 1927-2001. Cancer 2003;97:425-40.
30. Borthakur G, Estey E. Therapy-related acute myelogenous leukemia and myelodysplastic syndrome. Curr Oncol Rep 2007;9:373-7.
31. Litzow MR, Tarima S, Perez WS, et al. Allogeneic transplantation for therapy-related myelodysplastic syndrome and acute myeloid leukemia. Blood 2010;115:1850-7.
32. Lugthart S, van Drunen E, van Norden Y, van Hoven A, Erpelinck CAJ, Valk PJM, Beverloo HB, Lowenberg B, Delwel R. High EVI1 levels predict adverse outcome in acute myeloid leukemia: prevalence of EVI1 overexpression and chromosome 3q26 abnormalities underestimated. Blood 2008;111:4329-37.